TrkA is the receptor tyrosine kinase (RTK) for nerve growth factor (NGF) and stimulates NGF-dependent cell survival and dierentiation in primary neurons. TrkA expression in neuronal tumors also supports NGFdependent dierentiation of neuroblastomas and apoptosis of medulloblastomas. Phosphorylation of the activation loop tyrosines in RTK's are essential to activation as well as allosteric changes that facilitate substrate interaction and phosphorylation. Acidic amino acid substitution of the activation loop tyrosines in TrkA, Tyr 683 Tyr
684
, was performed to mimic the negative charges normally induced by ligand activation and receptor phosphorylation. A total of eight independent mutants containing single or double substitutions were generated for comparison. Herein, we demonstrate that acidic substitution of the activation loop tyrosines is sucient to induce allosteric changes required for constitutive TrkA kinase activity as well as phosphorylation of TrkA signaling proteins such as Shc, PLCg-1, FRS-2 and erk1/2. The strongest constitutively active TrkA mutants, GluAsp and AspGlu, support NGFindependent neuritogenesis and cell survival to levelsIntroduction Ligand binding to receptor tyrosine kinases (RTKs) stimulates the phosphorylation of regulatory tyrosines resulting in the activation and stabilization of the kinase. The subsequent phosphorylation of secondary tyrosines, in turn, generates binding sites for the recruitment and activation of downstream signaling molecules (Schlessinger and Ullrich, 1991; Heldin, 1995) .
Nerve growth factor (NGF), a member of the neurotrophin family of growth factors, binds two cell surface receptors, namely, a low-anity p75 NTR receptor and the tyrosine kinase receptor, TrkA (Meakin and Shooter, 1992; Glass and Yancopoulos, 1993) . NGF-stimulation of TrkA is essential for NGFdependent survival of neuronal cells under serum-free conditions (Yao and Cooper, 1995; Meakin et al., 1997) as well as NGF-dependent neurite outgrowth (Kaplan and Miller, 1997) . In neuronal tumors, TrkA activation stops proliferation and, in turn, stimulates dierentiation of neuroblastomas (Matsushima and Bogenmann, 1993; Poluha et al., 1995) and apoptosis of medulloblastomas (Muragaki et al., 1997) . A convenient in vitro model system to study NGFmediated biological responses is the PC12-derived cell line, nnr5. Nnr5 cells express low levels of TrkA and cannot dierentiate in response to NGF (Green and Greene, 1986 ) but NGF-dependent dierentiation can be reconstituted by transfection with a TrkA cDNA (Loeb et al., 1991) . Consistent with the model of RTK activation, NGF binding to TrkA stimulates receptor dimerization and trans-phosphorylation of the activation loop tyrosines which, in turn, induce allosteric changes to stabilize the kinase (Heldin, 1995) . TrkA then activates a variety of intracellular signaling molecules such as the Shc adapter proteins, Grb-2, Sos, phospholipase Cg-1 (PLCg-1), phosphatidylinositol 3-kinase (PI-3 kinase), Akt, Ras, mitogen-activated protein (MAP) kinases [or extracellular signal-regulated kinases (Erks)], c-yes, protein tyrosine phosphatase-1 C, the SH2-domain containing tyrosine phosphatase SH-PTP-2 ( Kaplan and Miller, 1997) , the CSK homologous tyrosine kinase, CHK (Yamashita et al., 1999) , and the adapter proteins FRS-2 (Kouhara et al., 1997; Meakin et al., 1999) , SH2-B and rAPS (Qian et al., 1998 ) are essential to receptor phosphorylation and activation while Tyr 499 and Tyr 794 are required for the tyrosine phosphorylation of Shc/ FRS-2 and PLCg-1/CHK, respectively, and serve as the docking sites for their high-anity binding to TrkA (Obermeier et al., 1994; Stephens et al., 1994; Meakin et al., 1999; Yamashita et al., 1999) .
Amino acid alignments between the b-chain of the insulin receptor kinase (IRK) , in the IRK (Hanks et al., 1988) . These observations suggest a model of TrkA activation based on crystallographic analyses of the IRK (Hubbard et al., 1994; Hubbard, 1997 in the IRK, is thought to stabilize an active conformation. Consistent with this model, phenylalanine mutagenesis of the catalytic core tyrosines in TrkA, TrkB, the IRK, the IGF-1 receptor, the FGF receptor and Met eectively inactivates kinase activity (Ellis et al., 1986; Wilden et al., 1992; Li et al., 1994; Longati et al., 1994; Hernandez-Sanchez et al., 1995; Stannard et al., 1995; Cunningham et al., 1997; McCarty and Feinstein, 1998) .
Herein, we substituted Tyr 683 , Tyr 684 in rat TrkA with acidic amino acids to mimic the negative charges induced by phosphorylation. Acidic substitution of regulatory tyrosine/serine residues in the catalytic Figure 1 Expression and tyrosine phosphorylation of mutant Trks. Cells were induced with Dox (2.0 mg/ml) for 24 h (+100 ng/ml NGF, 10 min) and lysates (500 mg) immunoprecipitated with anti-Trk antibodies and blotted with anti-p Tyr and anti-HA. (Brunet et al., 1994; Mansour et al., 1994) exemplifying the utility of this approach. We have evaluated eight combinations of single and double substitution mutants with respect to NGFindependent TrkA phosphorylation, activation of signaling molecules (Shc, PLCg-1, MAP kinase, and FRS-2), NGF-independent stimulation of neuronal dierentiation and NGF-independent cell survival. Interestingly, we ®nd that TrkA can be activated by this approach. While the stoichiometry of NGFindependent phosphorylation of Shc, PLCg-1, FRS-2 and MAPK is reduced relative to NGF-stimulated wild type TrkA, over-expression of the mutants supports NGF-independent neurite outgrowth and survival. Thus, constitutively active TrkA may be a novel therapeutic agent in the future treatment of neuronal tumors. ). The inducible tetracycline (tet) system (Gossen et al., 1995) was used to regulate TrkA expression since constitutive activation would induce cell cycle arrest and neurite outgrowth. Initially, nnr5 cells stably expressing the reverse tet transactivator (rtTa) were generated and one line, clone 24, was kept for further analysis. Clone rTa24 induces a 100-fold increase in the expression of an rtTA-dependent luciferase reporter gene in the presence of doxycycline (Dox; data not shown). Hemagglutinin (HA) Figure 3 NGF-independent neuritogenesis at 6 days following induction with Dox (min: 0.5 mg/ml or max: 2.0 mg/ml) (2006). Levels of Trk receptor expression are shown in Table 2 . nnr5, B5 and cells expressing AspAsp are shown in the absence and/or presence of 100 ng/ml NGF tagged TrkA mutants were stably expressed in rTa24 cells by co-transfection with pTK-hygro. A total of 612 clones were isolated and scored for TrkA expression in the presence of Dox (2 mg/ml). Two independent lines expressing each mutant were selected (see Table 1 ). Most lines (except AspAsp and GluTyr) express levels of TrkA similar to B2 cells (Meakin et al., 1997) following 3 h of induction. All mutants are expressed as an incompletely glycosylated intracellular form (p115) and as a fully glycosylated cell surface form (p140) (MartõÂ n-Zanca et al., 1989).
Results

Nnr5 cells expressing
NGF-independent phosphorylation of TrkA mutant receptors
To assay constitutive activity, cultures were assayed for NGF-independent and NGF-induced TrkA phosphorylation. Lysates from Dox-induced (2 mg/ml, 24 h), unstimulated or NGF stimulated, cells were immunoprecipitated with anti-Trk antibodies and assayed by Western blotting. Blots were analysed by densitometry to assay levels of receptor expression and phosphorylation relative to NGF-stimulated B2 cells (10 min and 24 h). As shown in Figure 1 , all mutants support NGF-independent autophosphorylation with a reduced stoichiometry relative to NGF-activated wild type TrkA. Autophosphorylation of TyrAsp is the highest and does not change in response to NGF. In contrast, tyrosine phosphorylation of the other mutants is induced by NGF (Figure 1 ). In addition, with the exception of TyrGlu, autophosphorylation of the single mutants is higher than the double mutants. All mutants express the mature 140 kDa form; thus, the low level of phosphorylation by some mutants is not a consequence of intracellular trapping.
To determine whether the reduced autophosphorylation of the mutants is attributable to decreased kinase activity, an in vitro kinase assay was performed. Mutant Trks were transiently expressed in Cos cells, immunoprecipitated and assayed for kinase activity using the exogenous substrate, poly Glu, Tyr (4 : 1), under non-saturating conditions (Meakin and Shooter, 1991) . To ensure that dierences in activities were not attributable to transfection eciencies, a fraction of each immunoprecipitate was assayed for receptor expression before assaying activity. As shown in Figure 2a , receptor expression varied only slightly between each transfection. Blots were analysed by densitometry and aliquots from each kinase reaction, containing similar levels of receptor, were analysed by SDS ± PAGE. As shown in Figure 2b ,c, all mutants display kinase activity and can phosphorylate the substrate poly Glu, Tyr (4 : 1) to levels signi®cantly higher than kinase inactive TrkA. With the exception of TyrAsp and TyrGlu, which retain intrinsic activity comparable to wild type TrkA, the mutants display in vitro kinase activity approximately 30 ± 35% of wild type TrkA. Similar results were obtained in three independent experiments. For comparison, mutants containing PhePhe, AsnGln or GlnAsn were also assayed ( Figure 2d ) and found to be only 5 ± 10% as active as wild type TrkA. The PhePhe substitution has previously been shown to functionally inactivate TrkA (Cunningham et al., 1997) .
Neuritogenesis
Neurite outgrowth was assessed in two lines induced to express each mutant. In general, neurite outgrowth was maximal by 5 days and correlated with receptor expression. As shown in Figure 3 , all mutants, except AspAsp, stimulated neuritogenesis in the absence of NGF. Neurite outgrowth by the mutants consistently lagged by 24 ± 36 h relative to NGF-stimulated B2 cells, presumably re¯ecting, at least in part, time required for expression, activation and signaling. As shown in Figure 4a (max. Dox) and Figure 4b (min. Dox), the highest level of NGF-independent neuritogenesis was observed in cells over-expressing the AspGlu and GluAsp mutants and corresponded to 50 ± 65% of NGF-stimulated B2 cells. By comparing the dierentiative responses by the mutant Trks, relative to their level of expression (Table 2) , a hierarchy of dierentiation is generated; namely, GluAsp = AspGlu4 GluGlu4GluTyr4 TyrAsp4 Asp Tyr=TyrGlu4AspAsp.
Neurite outgrowth assays were also performed in the presence of NGF to determine if the mutations, in particular AspAsp, blocked kinase activation. As shown in Figure 4c , the same hierarchy of neuritogenesis is observed with the exception that the AspAsp mutant regains neurite outgrowth comparable to GluAsp and AspGlu. A second group of receptors, GluGlu, GluTyr, and TyrAsp (clone 12), support neuritogenesis between 45 and 55% of B2 cells. The most severely compromised receptors, AspTyr and TyrGlu, stimulate neuritogenesis to levels only 8 ± 10% of NGF-stimulated wild type TrkA despite high levels of expression, phosphorylation and kinase activity (Figures 1 and 2 ). For comparison, we also assayed AsnGln and GlnAsn mutants and found that they induce NGF-independent neurite outgrowth in only 3 ± 6% of transected cells (Figure 5a,b) . This likely re¯ects decreased kinase activity ( Figure 2d ) and is partially restored, following NGF-stimulation, to 70 ± 80% of wild type TrkA. Thus, it is the acidic nature of residues 683 and 684, rather than their hydrophilicity, which is essential in activating TrkA.
Survival assays
Cells expressing each mutant were cultured for 3 ± 5 days (Dox, 2 mg/ml) and assayed for survival in serum- Figure 6 , the AspGlu mutant supports survival similar to NGF-activated B2 cells. In contrast, survival by AspAsp was indistinguishable from background but could be rescued to near wild type levels by NGF (data not shown). With the exception of AspAsp, the other mutants were not stimulated by NGF (data not shown). As shown in Figure 6 , the GluGlu, AspGlu, GluAsp, AspTyr and GluTyr mutants support survival between 70 and 100% of NGF-stimulated B2 cells. Similar results were obtained in four independent experiments. NGF-independent tyrosine phosphorylation of Shc and MAP kinase/erk proteins NGF stimulation of TrkA activates the Ras signaling pathway, in particular, the tyrosine phosphorylation of Shc and MAPK. Cells induced to express the mutants were assayed for NGF-independent Shc tyrosine phosphorylation by immunoprecipitation and Western blotting. As shown in Figure 7a ,b, most mutants induce Shc tyrosine phosphorylation to levels comparable to NGF-activated B2 cells (10 min). Phosphorylation of Shc by GluTyr (clone 11) was approximately 20 ± 40% lower; however, the level of receptor expression was also approximately 2.56lower ( Figure  7c ). Although the AspAsp mutant was severely compromised (only twofold induction over background), this was not attributed to low levels of receptor expression (Figure 7c ). Co-immunoprecipitation of tyrosine phosphorylated TrkA was detected in all immunoprecipitates except AspAsp (Figure 7a ). Similar results were found for both lines expressing each mutant.
Next, NGF-independent phosphorylation of MAPK was determined by Western blotting with antibodies directed against the active form of MAPK. As shown in Figure 8a , all mutants, except AspAsp, support MAPK activation at 24 h. Reprobing the blot with a pan-MAPK antibody con®rms that comparable amounts of lysates were loaded in each lane (Figure 8b ). Similar results were obtained at 48 h (data not shown). As observed above for Shc, the stoichiometry of MAPK phosphorylation is reduced relative to NGF-stimulated wild type TrkA but lines over-expressing the residues of human/rat TrkA resulting in its phosphorylation and activation Obermeier et al., 1994) . Cells expressing the mutants were assayed for NGF-independent PLCg-1 phosphorylation by immunoprecipitation and Western blotting. As shown in Figure 9a , NGFindependent tyrosine phosphorylation of PLCg-1 was detected after 24 h of receptor expression although the stoichiometry was reduced relative to wild type TrkA. Interestingly, the AspAsp mutant phosphorylates PLCg-1 to levels comparable to AspGlu and GluTyr (Figure 9a ) in the absence of neurite outgrowth (Figures 3 and 4 ) consistent with the model that PLCg-1 is not essential for neuritogenesis .
NGF-independent tyrosine phosphorylation of FRS-2
NGF stimulation of PC12 cells induces the tyrosine phosphorylation of SNT/FRS-2 (80 ± 90 kDa), a dierentiation-speci®c target of NGF and FGF receptors (Rabin et al., 1993; Kouhara et al., 1997; Meakin et al., 1999) . We generated a polyclonal antibody to FRS-2 and, as shown in Figure 10a , demonstrate that it immunoprecipitates tyrosine phosphorylated FRS-2 from NGF-stimulated B5 cells (Meakin et al., 1997) . FRS-2 co-migrates with the SNT protein identi®ed with p13 suc1 agarose ( Figure 10a, lane 1) . Cell lines were then induced to express mutant Trk's and assayed for FRS-2 phosphorylation by immunoprecipitation and Western blotting. As shown in Figure 10b , all mutants, except AspAsp, induce phosphorylation of FRS-2. The lower levels induced by GluTyr likely re¯ects low level of receptor expression (Figures 10d) . In general, we ®nd that FRS-2 phosphorylation correlates with the ability of individual mutants to stimulate neurite outgrowth. 
Discussion
Ligand activation of receptor tyrosine kinases (RTK's) stimulates the phosphorylation of intracellular tyrosines, within the activation loop, resulting in the destabilization of auto-inhibitory forms in favor of catalytically active conformations. While substitution of activation loop residues does not always generate active enzymes (Robbins et al., 1993; Weinmaster and Pawson, 1986; Webster et al., 1996; Raoni et al., 1998; Alessi et al., 1994) , success will depend on understanding how each kinase functions. In this regard, it is clear that there are dierences in the auto-inhibitory mechanisms regulating dierent RTK's. For example, the catalytic core tyrosines of the FGF receptor (FGFR) are not required for auto-inhibition in the absence of ligand; rather, auto-inhibition involves amino acids C-terminal to the activation loop (Mohammadi et al., 1996) . Thus, constitutive activation of the FGFR3 is achieved by introducing negative or positive charges carboxy-terminal to the activation loop tyrosines rather than substitution of the activation loop tyrosines themselves (Webster et al., 1996) .
In contrast, the activation loop tyrosines are essential for auto-inhibition of the IRK in the absence of ligand (Hubbard et al., 1994) . Since TrkA is most closely related to the IRK in the kinase superfamily (Hanks et al., 1988) , we assayed the role of the activation loop tyrosines in the mechanism of TrkA activation. Speci®cally, we substituted Y 683 , Y 684 in rat TrkA with acidic amino acids in an eort to disengage auto-inhibitory interactions with the catalytic base (Hubbard et al., 1994) and drive constitutive kinase activation. Mutant receptors have been expressed in both Cos and nnr5 cells and assayed for intrinsic kinase activity, NGF-independent activation of signaling intermediates and the reconstitution of cell survival and neuritogenesis. Collectively, these data support a hierarchy of mutant TrkA receptor activity: GluAsp = AspGlu4 GluGlu4 TyrAsp=GluTyr4Asp Tyr=TyrGlu4AspAsp.
Autophosphorylation and biological responsiveness
While the intracellular domain of TrkA has not been crystallized, studies on the b-chain of the IRK (Hubbard et al., 1994; Hubbard, 1997 ) have provided (Hubbard, 1997) . Finally, Tyr 679 in TrkA (Tyr 1158 in the IRK) is predicted to be solvent exposed in an active conformation (Hubbard, 1997) suggesting a possible role in substrate interaction.
With this model, we have assayed NGF-dependent and independent autophosphorylation of the mutants. Phosphorylation levels will be aected by the replacement of either one or two Tyr residues and by the possibility that dierent pTyr sites dierentially contribute to the total pTyr content of TrkA. Interestingly, the Tyr 683 Asp 684 mutant shows NGFindependent autophosphorylation and kinase activity similar to NGF-activated wild type TrkA (Figures 1  and 2 ) yet it shows reduced neuritogenesis and survival activity. This discrepancy is surprising and not well understood but presumably re¯ects either absolute dierences in the activation of intracellular substrates, changes in the kinetics of substrate activation and/or changes in the stoichiometric relationships of intracellular targets. Non-linearity between the level of TrkA phosphorylation and neuritogenesis has previously been observed (Cunningham et al., 1997) .
In contrast, other mutants such as GluGlu, AspGlu, GluAsp display lower levels of receptor phosphorylation (Figure 1 ), due in part to the substitution of two phosphotyrosine residues, yet stimulate neurite outgrowth that is approximately 50 ± 65% of NGFstimulated wild type TrkA (Figure 4b) . Interestingly, the double substitution mutants that contain at least one glutamate residue retain signi®cant biological responsiveness in comparison with AspAsp. The apparent preference for glutamic acid at either Tyr 683 or Tyr 684 may re¯ect the fact that both pTyr residues are predicted to participate in salt bridge formation in an active state (Hubbard, 1997) ; thus, the longer carbon side chain of glutamate may facilitate this process. Since GluAsp and AspGlu receptors retain kinase activities that are only 30 ± 35% of wild type
TrkA, yet they demonstrate 50 ± 65% neurite outgrowth and 80 ± 100% cell survival activities comparable to NGF-stimulated wild type TrkA, only a fraction of functional receptors are required. Moreover, since hydrophilic homologues such as AsnGln or GlnAsn do not induce NGF-independent kinase activation or neurite outgrowth (Figures 2 and 5) , it is clear that it is the negative charge of residues 683 and 684, and not their hydrophilic nature, that is required for the release of auto-inhibition and subsequent activation. This may re¯ect a requirement for interaction between negatively charged residues in the activation loop with the positively charged COOHterminal tail in order to stabilize the kinase consistent with a model previously suggested by Cunningham et al. (1997) .
Interestingly, similar mutagenesis studies on the IRK demonstrate that substitution with Asp or Glu fails to activate the kinase and/or to permit insulin-dependent activation (Zhang et al., 1991) . As observed with IRKAspAsp (Zhang et al., 1991) , TrkA-AspAsp is defective in neuritogenesis, survival and NGF-independent autophosphorylation. However, TrkA-AspAsp becomes fully functional in the presence of NGF providing an argument, at least in part, against identical mechanisms regulating IRK and TrkA activation. A likely explanation for the signi®cant change in biological responsiveness of TrkA-AspAsp is that NGF induces phosphorylation of the ®rst catalytic core tyrosine, Tyr 679 , as well as the juxtamembrane residue, Tyr
499
. As discussed below, as well as in the literature, phosphorylation of Tyr 794 is not essential to TrkA-dependent neurite outgrowth .
Signal transduction
Upon stimulation, TrkA activates numerous intracellular signaling molecules including the Shc adapter proteins, Grb-2/Sos, Ras, Map kinase (MAPK), phosphatidylinositol-3 kinase, src, phospholipase Cg-1, tyrosine phosphatases such as SH-PTP-1, SH-PTP-2 (Kaplan and Miller, 1997), the Csk homologous tyrosine kinase, CHK (Yamashita et al., 1999) , and the more recently described signaling adapters, rAPS, SHB (Qian et al., 1998) and FRS-2 (Meakin et al., 1999) . As stated above, TrkA can stimulate a number of dierential responses in cells including mitogenesis in non-neuronal cells, dierentiation and survival in neurons as well as dierentiation and apoptosis in neuronal tumors such as neuroblastomas and medulloblastomas respectively.
While not all of these intracellular targets directly interact with TrkA, several studies indicate that Tyr 499 is essential to the phosphorylation and receptor binding of the PTB domains of Shc (Obermeier et al., 1993; Stephens et al., 1994) and FRS-2 (Meakin et al., 1999) . As discussed above, Tyr 794 is essential for the phosphorylation and binding of PLCg-1 and the soluble tyrosine kinase, CHK (Yamashita et al., 1999) . The precise role of PLCg-1 in TrkA signaling is not clear; however, its phosphorylation is dependent on the phosphorylation of all three activation loop tyrosines which, in turn, facilitate interaction with the basic residues in the carboxyterminal tail (Cunningham et al., 1997) . Consistent with this model, the TrkA mutants described here, even AspAsp, mimic the acidic regulatory phosphotyrosines and induce allosteric changes to facilitate PLCg-1 phosphorylation.
Within recent years, the cellular pathways regulating NGF-dependent induction of cell survival under serum-free conditions and the prevention of apoptosis have become fairly well understood. In this respect, activation of PI-3 kinase appears to be essential and sucient to stimulate NGF-dependent PC12 cell survival and to prevent apoptosis in the absence of serum (Yao and Cooper, 1995; Meakin et al., 1997) . Thus, it is likely that the TrkA mutants which support serum-free survival retain PI-3 kinase activity. PI-3 kinase can be directly or indirectly recruited into the signaling pathways stimulated by RTK's. While the mechanism(s) utilized by TrkA are not fully understood, it is likely that there is more than one pathway. In this respect, PI-3 kinase appears to be functionally downstream of Ras (Rodriguez-Viciana et al., 1994; Hallberg et al., 1998) . In fact, a Shc-minus human TrkA receptor exhibits a signi®cant loss of NGF-activated PI-3 kinase activity in vitro (Baxter et al., 1995; Hallberg et al., 1998) . However, substitution of the ®rst catalytic tyrosine, Tyr 670 (human TrkA), also signi®cantly decreases PI-3 kinase activity, with minimal eects on Shc-dependent pathways (Cunningham et al., 1997) , suggesting that there is more than one route to PI-3 kinase activation.
Over the last several years, there has been considerable interest in the molecular mechanisms underlying TrkA-dependent mitotic arrest and differentiation. In this regard, sustained activation of the MAPK pathway has been suggested as an essential component of this process Kaplan and Miller, 1997) . Sustained MAPK activity, in turn, stimulates the expression of the p21 CIP/Waf-1 inhibitor of cell cycle progression (Woods et al., 1997) providing a functional link between TrkA signaling, mitotic arrest and neuronal dierentiation. Presently, NGF-induced activation of Rap1, via Crk/C3G, is thought to be essential for prolonged MAPK activation while activation of Ras, via Grb/Sos, is thought to regulate an immediate-early phase of activation (York et al., 1998) . From these same studies, though, decreasing MAPK activation, via a dominant negative Rap1 mutant, is not sucient to block neurite outgrowth of PC12 cells (York et al., 1998) suggesting that additional pathways are essential. Other potential pathways include the SH2 domain-containing tyrosine phosphatase, SH-PTP-2 (Wright et al., 1997) , the p38 MAPK (Morooka and Nishida, 1998) and FRS-2 (Kouhara et al., 1997; Meakin et al., 1999) . In this regard, over-expression of catalytically inactive SH-PTP-2 blocks NGF-dependent PC12 cell dierentiation (Wright et al., 1997) indicating an essential role of SH-PTP-2 in this process. SH-PTP-2 transiently associates with TrkA (Goldsmith and Koizumi, 1997) and also associates with activated FRS-2 (Kouhara et al., 1997; Meakin et al., 1999) suggesting a model in which activation of both prolonged MAPK and FRS-2 are the essential pathways to neuronal dierentiation. Consistent with this model, over-expression of FRS-2 can functionally reconstitute mitotic arrest and dierentiation by a non-responsive TrkA receptor mutant (Meakin et al., 1999) .
Because of this model, we correlated neuritogenesis to the activation of both pathways. In general, our ®ndings show that the mutant Trks which support long-term activation of Shc, FRS-2 and MAPK also induce neuritogenesis. Thus, it was not immediately apparent why none of the mutant TrkAs did not fully restore neuritogenesis. One possible explanation may be the incomplete activation of additional pathways and/or changes in the stoichiometric activation of intracellular targets.
In conclusion, we show that TrkA activation, neuritogenesis and cell survival can be stimulated by substituting negatively charged residues in place of the activation loop tyrosines (Tyr   683   , Tyr   684 ). These observations raise the possibility of using constitutively active TrkA as a therapeutic agent to drive mitotic arrest and dierentiation of neuroblastomas (Matsushima and Bogenmann, 1993; Poluha et al., 1995) and/or apoptosis of medulloblastomas (Muragaki et al., 1997) . Moreover, these mutants will provide a novel opportunity to examine the possibility that the catalytic tyrosines themselves may serve a role in the direct recruitment and activation of intracellular signaling molecules.
Material and methods
Antibodies, NGF and reagents
Rabbit antibodies to Trk (C-terminal 14 aa) and FRS-2 (   283   NTEWDTGYDSDERRD   297 ) were generated using standard techniques. The monoclonal antibody to pTyr (PY20) and the horseradish peroxidase coupled anti-pTyr antibody, RC20, were from Transduction Labs. The antibody to Shc was from J McGlade (Hospital for Sick Children, Toronto, Canada). The antibody to PLCg-1 and p13 suc1 agarose were from UBI. Rabbit antibody to MAPK was from S Pelech (Kinetek Biotec. Corp., Vancouver, Canada). Antibodies to active MAPK were from Promega. Antibodies to HA and hygromycin B were from Roche Diagnostics. b-NGF was from Harlan Bioproducts for Science. G418 was from Gibco. Doxycyline was from Sigma.
Plasmids
HA-tagged rat TrkA (MacDonald and Meakin, 1996) was used to generate the Tyr 683 Tyr 684 mutants termed GluGlu, AspGlu, GluAsp, AspAsp, AspTyr, GluTyr, TyrAsp, TyrGlu, AsnGln, GlnAsn and PhePhe with mutagenic sense primers: 5'-AGC ACA GAC GAG GAG CGT GTG GGA G-3', 5'-AGC ACA GAC GAC GAG CGT GTG GGA G-3', 5'-AGC ACA GAC GAG GAC CGT GTG GGA G-3', 5'-AGC ACA GAC GAC GAC CGT GTG GGA G-3, 5'-ACA GAC GAC TAC CGT GTG GGA GGT C-3', 5'-ACA GAC GAG TAC CGT GTG GGA GGT C-3', 5'-GAC TAC GAC CGT GTG GGA GGT C-3', 5'-GAC TAC GAG CGT GTG GGA GGT CGG-3', 5'-GCA CAG ACA ACC AAC GTG TGG GAG-3', 5'-GCA CAG ACC AAA ACC GTG TGG GAG-3' and 5'-GCA CAG ACT TCT TCC GTG TGG GAG-3'. PCR products were sequenced and subcloned into pCMX and the Tet-inducible vector, pUHD10-3 (Gossen and Bujard, 1992) . pUHD172-1 neo, which drives high levels of reverse tetracycline trans-activator (rtTA) expression (Gossen et al., 1995) and pUHC13-3, which contains an rtTA sensitive luciferase gene (Gossen and Bujard, 1992) , were gifts from H Bujard (U.C. Berkeley, CA, USA).
Construction of mutant TrkA expressing cell lines
Nnr5 cells expressing rTa were generated by electroporation with pUHD172-1 neo and G418 (500 mg/ml) selection. Cells were re-electroporated with pUHC13-3 and seeded in duplicate. Dox (2 mg/ml) was added to one dish and cells were assayed for luciferase activity at 48 h (Promega). Clone rTA24 demonstrated a 100-fold induction of luciferase activity. Stable expression of the mutants was generated by co-transfection of pUHD10-3/Trk (20 mg) and 1 mg pTKhygro. Between 24 and 72 clones for each construct were analysed for Dox-induced receptor expression by Western blotting with anti-pTyr (RC20) and anti-HA antibodies. Two lines expressing each mutant were kept. Nnr5 cells expressing wild type TrkA (B2, B5) have been described (Meakin et al., 1997) .
Neurite response and cell survival assays Dox-induced (0.02 ± 2.0 mg/ml) neurite outgrowth was assayed (+100 ng/ml NGF) at 1 week by counting the number of cells with neurites (42 cell body lengths) in three independent ®elds (300 to 500 cells). Serum-free survival was determined by the reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT assay; Promega), in quadruplicate, as described (Meakin et al., 1997) . Samples were corrected for non-speci®c adsorption.
Transient neurite response assays
Nnr5 cells (4610 6 ) were electroporated with 1 mg of pEGFP (Clontech) and 10 mg of pCMX-HATrkA vectors. Cells were split and assayed for neurite outgrowth in the absence and presence of 100 ng/ml NGF. After 3 days, cells were scored for EGFP expression by epi¯uoresence to determine the percentage of transfected cells that contained neurites greater than 2 cell body lengths. Two hundred green cells from three independent frames (n=2) were scored.
Protein determinations and TrkA immunoprecipitations
Cells were stimulated with Dox (2 mg/ml) and lysed in NP-40 buer (Meakin and MacDonald, 1998) containing 1 mM phenylmethylsulfonyl¯uoride, 1 mM sodium orthovandate, 2 mg/ml leupeptin, and 10 mg/ml aprotinin. Equal amounts of protein (BioRad D c Kit) were immunoprecipitated with antibodies to Trk and Western blots were probed with anti-HA antibodies (Meakin et al., 1999) . Trk expression was estimated by densitometry (Bio-Rad, Model GS-700) relative to B2 cells (Meakin et al., 1997) .
In vitro kinase assay
Lysates from transfected Cos cells (1610 6 ), normalized for protein content, were immunoprecipitated with anti-Trk or control IgG antibodies for 2 h at 48C (Meakin and Shooter, 1991) . Precipitates were washed and one-tenth was analysed for receptor expression by Western blotting with anti-HA. The kinase reaction was performed with the remaining immunoprecipitate using the synthetic co-polymer, poly Glu-Tyr (4 : 1) under non-saturating, linear conditions (Meakin and Shooter, 1991) . Based on minor dierences in Trk expression, fractions of each reaction were analysed by 10% SDS ± PAGE (Meakin and Shooter, 1991) and phosphorimaging (Molecular Dynamics).
Shc, PLCg-1, MAP kinase and SNT assays Cells were cultured with Dox (2 mg/ml) for 24 ± 48 h. B2 cells were treated with 100 ng/ml b-NGF. Cells were lysed in NP-40 buer and equal amounts of protein (500 mg to 1 mg) were immunoprecipitated with rabbit anti-Shc (7.5 mg) or mouse anti-PLCg-1 (0.5 mg) at 48C. SNT was immunoprecipitated with 75 mg of p13 suc1 agarose (UBI) for 2 ± 3 h and FRS-2 was immunoprecipitated (NP-40 or RIPA lysates (Meakin and MacDonald, 1998) ) with 10 ml of preimmune or anti-FRS-2 antisera. Blots were probed with RC20 (Meakin and MacDonald, 1998) and reprobed with 2 mg/ml rabbit anti-Shc, 0.1 mg/ml mouse anti-PLCg-1 (Meakin and MacDonald, 1998) or anti-FRS-2 (1/1000). Whole cell lysates (10 mg) were analysed by SDS ± PAGE and blots were probed with anti-active MAPK (1 : 20 000). Membranes were re-probed with rabbit anti-MAPK antibodies (1 : 10 000).
